The statement of the Polish Society of Allergology regarding necessary changes in therapeutic program of severe IgE-mediated allergic asthma with omalizumab

Zbigniew Bartuzi; Anna Bodzenta-Łukaszyk; Piotr Kuna; Izabela Kupryś -Lipińska; Ewa Niżankowska -Mogilnicka; Bolesław Samoliński

doi:10.5603/PiAP.2015.0053

Vol 83, No 4 (2015)

Review paper

Submitted: 2015-07-09

View PDF

Download PDF file

View HTML

Get Citation

The statement of the Polish Society of Allergology regarding necessary changes in therapeutic program of severe IgE-mediated allergic asthma with omalizumab

Zbigniew Bartuzi, Anna Bodzenta-Łukaszyk, Piotr Kuna, Izabela Kupryś -Lipińska, Ewa Niżankowska -Mogilnicka, Bolesław Samoliński

DOI: 10.5603/PiAP.2015.0053

Pubmed: 26166795

Pneumonol Alergol Pol 2015;83(4):335-338.

Vol 83, No 4 (2015)

REVIEWS

Submitted: 2015-07-09

Abstract

Not available

Abstract

Not available

Full Text:

View PDF

Download PDF file

View HTML

Get Citation

About this article

Title

The statement of the Polish Society of Allergology regarding necessary changes in therapeutic program of severe IgE-mediated allergic asthma with omalizumab

Journal

Advances in Respiratory Medicine

Issue

Vol 83, No 4 (2015)

Article type

Review paper

Pages

335-338

DOI

10.5603/PiAP.2015.0053

Pubmed

26166795

Bibliographic record

Pneumonol Alergol Pol 2015;83(4):335-338.

Authors

Zbigniew Bartuzi
Anna Bodzenta-Łukaszyk
Piotr Kuna
Izabela Kupryś -Lipińska
Ewa Niżankowska -Mogilnicka
Bolesław Samoliński